ENVERIC BIOSCIENCES INC
ENVB·29405E505·US·Common Stock·Healthcare - Biotechnology-13D/G
ENVB (ENVERIC BIOSCIENCES INC) is held by 8 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($62,368), UBS Group AG ($7,008), JONES FINANCIAL COMPANIES LLLP ($1,880). Net institutional sentiment: Mixed.
8
Holders
Avg rating(2 Elite)
$71,363
Total Value
60% (10)
Fund Consensus
3 buying - 2 selling
Who's Trading
ActivistEJEASTON JEFF7.9%May 15, 2026
ActivistMPMitchell P. Kopin5.0%Feb 2, 2026
ActivistATAdvisorShares Trust1.7%Jan 5, 2026
ActivistBLBraeden Lichti0.0%Dec 10, 2025
ActivistNINorthstrive Fund II LP0.0%Dec 10, 2025
ActivistAYAyrton Capital LLC10.0%Nov 13, 2025
ActivistMPMitchell P. Kopin0.4%Sep 24, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer